Kuribayashi, T., Kinoshita, R., Ninomiya, K., Makimoto, G., Kubo, T., Rai, K., . . . Ohashi, K. Plasma S100A8/A9 level predicts response to immune checkpoint inhibitors in patients with advanced non-small cell lung cancer. Nature Portfolio.
Chicago Style (17th ed.) CitationKuribayashi, Tadahiro, et al. Plasma S100A8/A9 Level Predicts Response to Immune Checkpoint Inhibitors in Patients with Advanced Non-small Cell Lung Cancer. Nature Portfolio.
MLA (9th ed.) CitationKuribayashi, Tadahiro, et al. Plasma S100A8/A9 Level Predicts Response to Immune Checkpoint Inhibitors in Patients with Advanced Non-small Cell Lung Cancer. Nature Portfolio.
Warning: These citations may not always be 100% accurate.